Goodbye job applications, hello dream career
Seize control of your career and design the future you deserve with LW career
GET STARTED

Bakers and Clutz advise on pharmaceutical offload (1)

Firms: Baker & McKenzie (Valeant Pharmaceuticals); Clayton Utz (Ironbridge and Archer Capital) Deal: NYSE-listed, Canada-based Valeant Pharmaceuticals acquisition of Australian-based iNova…

user iconLawyers Weekly • 11 January 2012 • Big Law
expand image

Firms: Baker & McKenzie (Valeant Pharmaceuticals); Clayton Utz (Ironbridge and Archer Capital)

 
 

You’re out of free articles for this month
Deal: NYSE-listed, Canada-based Valeant Pharmaceuticals acquisition of Australian-based iNova Pharmaceuticals from Ironbridge and Archer Capital. Deal officially closed on 21 December

Area: M&A

Value: $625 million upfront and up to an additional $75 million in potential milestones

Key players: The Bakers team was led by Sydney-based partner David Egan and associate Michael Dearden

Tags
You need to be a member to post comments. Become a member for free today!